Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, January 23, 2013
CAMO Software, leaders in multivariate data analysis solutions, today announced the release of a new version of the Unscrambler® X Process Pulse software for process monitoring. The software is designed to be used by laboratory staff, technical ...
read more
Fresenius Kabi announced today the immediate availability in the United States of Remifentanil Hydrochloride for Injection.
read more
Renaissance Acquisition Holdings, LLC (“Renaissance”), a portfolio company of RoundTable Healthcare Partners (“RoundTable”), an operating-oriented private equity firm focused exclusively on the healthcare industry, announced today that it has ...
read more
Wednesday, April 10, 2019
ReNeuron has signed a license agreement with Shanghai Fosun Pharmaceutical for the development, manufacture and commercialization of ReNeuron's CTX and hRPC cell therapy programs in China.
read more
Rentschler Biopharma, a leading global contract development and manufacturing organization (CDMO) today provided an update on progress at Rentschler ATMP Ltd., the Company’s dedicated cell and gene therapy facility located in Stevenage, UK, including...
read more
Thursday, February 13, 2020
Rentschler Biopharma announced the hiring of Grace Kim as Vice President Business Development – North America and APAC.
read more
Wednesday, November 06, 2019
Rentschler Biopharma SE is taking the first step in the expansion project to grow its U.S. footprint and establish a Center of Excellence in North America.
read more
Rentschler Biopharma SE will further develop the existing collaboration in Japan with Summit Pharmaceuticals International Corporation.
read more
Thursday, December 13, 2018
Rentschler Biopharma announced Dr. Jesús Zurdo will join the company as Senior Vice President Process Science and Innovation, effective January 01, 2019.
read more
Wednesday, December 26, 2018
Rentschler Biopharma announced Henning Gerschewski will join the company as Vice President Manufacturing Science and Technology, effective January 1, 2019.
read more
Wednesday, February 28, 2018
Rentschler Biopharma SE announced that Federico Pollano has joined the company as Senior Vice President, Business Development, effective March 1, 2018.
read more
Wednesday, January 30, 2019
Rentschler Biopharma announced the appointment of Dr. Christian Hunzinger as the new Senior Vice President Project Management, effective from January 15, 2019.
read more
Monday, November 21, 2022
Rentschler Biopharma, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, announced, that following seven years of accelerated growth at Rentschler Biopharma under his leadership as Chief Executive ...
read more
Rentschler Biopharma announced the company has completed the acquisition of a manufacturing facility from an affiliate of Shire.
read more
Rentschler Biopharma has entered into a collaboration with Genmab for the development and manufacture of bispecific antibodies generated with Genmab’s DuoBody technology platform.
read more